Profile: Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

2:44pm EST
Change (% chg)

$-2.90 (-3.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Company’s products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. The Company’s products are marketed directly to doctors, hospitals and other healthcare facilities in the United States. Internationally, its products are sold in over 100 countries through company-owned sales subsidiaries and branches as well as third-party dealers and distributors. The Company segregates its reporting into three reportable business segments: Reconstructive, MedSurg, and Neurotechnology and Spine.


Reconstructive products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries. The Company brings patients and physicians advanced implant designs and specialized instrumentation that make orthopaedic surgery and recovery. In 2013, the Company launched the Tritanium Cementless Baseplate for its Triathlon Knee System (TKA), which combines biologic fixation with Triathlon’s ideal kinematics to provide surgeons with a superior option for cementless TKA. It also launched the Secur-Fit Advanced Femoral Hip Stem aimed at accurately restoring biomechanics by Stryker Orthopaedics Modeling and Analytics system.

The Company competes with Zimmer Holdings, Inc. (Zimmer), Johnson & Johnson, Biomet, Inc. and Smith & Nephew plc.


The Company’s MedSurg products include surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices as well as other medical device products used in a variety of medical specialties. The Company launched System 7, the next generation of heavy duty surgical power tools in 2012. These tools are used in total joint procedures, such as hip and knee replacements, and offer the latest in advanced cutting technology. It also launched the 1488 HD 3-Chip Endoscopic Camera System, which utilizes advanced CMOS technology and premium optics to provide a clear bright image designed to enhance patient outcomes and launched Power-LOADTM, its cot fastener system that lifts and lowers the cot into and out of ambulances, thereby reducing spinal loads and the risk of cumulative trauma injuries to emergency responders.

The Company competes with Zimmer, Medtronic, Inc., CONMED Corporation, B. Braun Melsungen AG, Smith & Nephew plc, Arthrex, Inc., Karl Storz GmbH & Co., Olympus Optical Co. Ltd., Hill-Rom Holdings, Inc. and Kinetic Concepts, Inc.

Neurotechnology and Spine

The Company’s Neurotechnology and Spine products include both neurosurgical and neurovascular devices. Its neurotechnology offering includes products used for minimally invasive endovascular techniques; a line of products for traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also develops, manufactures and markets spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

The Company competes with Johnson & Johnson, Covidien, Medtronic, Inc., DePuy Synthes, Nuvasive, Inc. and Globus Medical.

Company Address

Stryker Corp

2825 Airview Blvd
PORTAGE   MI   49002-1802
P: +1269.3892600
F: +1269.3851062

Company Web Links

Search Stocks